Bottom line
What does FPHAX hold?
FPHAX held 57 positions as of May 31, 2026. Its largest holding is ELI LILLY and CO at 28.78% of the fund, and the top 10 positions add up to 73.8%. By asset type it is 99% stocks, 1% preferred stock, 0% bonds.
Updated Jul 24, 2026
FPHAX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | ELI LILLY and CO | Stocks | 28.78% | $431.8M |
| 2 | Gsk Plc GSK PLC SPONS ADR |
Stocks | 8.17% | $122.6M |
| 3 | Viatris Inc | Stocks | 5.45% | $81.8M |
| 4 | Ucb Sa | Stocks | 5.09% | $76.4M |
| 5 | MERCK and CO INC MERCK and CO INC NEW |
Stocks | 4.74% | $71.2M |
| 6 | Roche Holding Ag | Stocks | 4.54% | $68.2M |
| 7 | Legend Biotech Corp LEGEND BIOTECH CORP SPON ADR |
Stocks | 4.53% | $68.0M |
| 8 | Astrazeneca Plc | Stocks | 4.22% | $63.4M |
| 9 | Elanco Animal Health Inc | Stocks | 4.15% | $62.3M |
| 10 | Jazz Pharmaceuticals Plc JAZZ PHARMA PLC |
Stocks | 4.09% | $61.4M |
| 11 | Gilead Sciences Inc | Stocks | 3.97% | $59.5M |
| 12 | JOHNSON and JOHNSON | Stocks | 3.77% | $56.6M |
| 13 | Royalty Pharma Plc | Stocks | 2.67% | $40.1M |
| 14 | Fidelity Revere Street Trust Fidelity Securities Lending Cash Central Fund |
Cash & short-term funds | 2.44% | $36.7M |
| 15 | Moderna Inc | Stocks | 1.57% | $23.6M |
| 16 | Intellia Therapeutics Inc | Stocks | 1.19% | $17.8M |
| 17 | Beam Therapeutics Inc | Stocks | 1.10% | $16.5M |
| 18 | Axsome Therapeutics Inc | Stocks | 1.08% | $16.2M |
| 19 | Biontech Se BIONTECH SE ADR |
Stocks | 1.04% | $15.7M |
| 20 | Xenon Pharmaceuticals Inc | Stocks | 0.82% | $12.4M |
| 21 | Ocular Therapeutix Inc | Stocks | 0.80% | $12.0M |
| 22 | Idexx Laboratories Inc IDEXX LABS INC |
Stocks | 0.61% | $9.1M |
| 23 | Swedish Orphan Biovitrum Ab | Stocks | 0.54% | $8.2M |
| 24 | Ptc Therapeutics Inc | Stocks | 0.54% | $8.1M |
| 25 | Capricor Therapeutics Inc | Stocks | 0.46% | $6.9M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 24, 2026